Current FDA-approved GLP-1 drugs available on the market include: Byetta (exenatide) Foundayo (orforglipron) Trulicity (dulaglutide), Victoza, Saxenda, Xultophy (liraglutide) Ozempic, Rybelsus, Wegovy (semaglutide) Mounjaro, Zepbound (tirzepatide) While all GLP-1 drugs can cause weight loss as a side effect, only Wegovy, Saxenda, Foundayo, and Zepbound are FDA approved for weight loss
Seven of these trials are expected to report results in 2026
Research recommends 1.2 to 1.6g of protein per kilogram of body weight daily to preserve muscle mass during weight loss 1
Overuse can potentially lead to red flags or recoupment
Incorrect application of chemical peels by medically unqualified professionals may cause severe damage, such as skin irritation, burns, or scarring
Sugar-sweetened soda consumption and risk of developing rheumatoid arthritis in women